Jd Medex Inc entered the industry of Drug Brokers in 2011 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 424210, which describes it as a Drug Brokers. For further clarification, the SIC classifies this business under the code 5122 and described it as a Drug Brokers. The business provides service to the B2B market.
To acquire more information, please contact Yury Akopyan by calling (323) 266-6776 during business hours. You can also write to the business’ Single Location at 2932 East Cesar East Chavez Avenue, Los Angeles, California CA 90033. You can also visit the company’s website at jdmedex.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Jd Medex Inc |
| Representative: | Yury Akopyan |
| Place of Business: | 2932 East Cesar East Chavez Avenue, Los Angeles, CA 90033 |
| Contact Number: | (323) 266-6776 |
| Website: | jdmedex.com |
| Type of Service: | Drug Brokers |
| SIC Number: | 5122 |
| NAICS Number: | 424210 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2011 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Jd Medex Inc is a company operating from Los Angeles, California providing professional Drug Brokers and relevant B2B variables. It was founded in 2011 and registered with the SIC code 5122 as Drug Brokers, and with the NAICS code 424210 as Drug Brokers.
With a current employee count of 1 to 4, Jd Medex Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Yury Akopyan at (323) 266-6776 for related queries, or to locate its Single Location using the coordinates 34.043527,-118.200676.
The Single Location can also be found at the street address 2932 East Cesar East Chavez Avenue in Los Angeles, California 90033 and can be engaged online through the company website at jdmedex.com, the company Twitter , and Facebook page .